Colorectal Neoplasms: all 5,734 studies

Page 58 of 58. Open to participants first (1,481), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00003446Phase 2
• Irofulven in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003441Phase 2
• Immunotherapy in Treating Patients With Resected Liver Metastases From Colon CancerCompletedNCT00003433Phase 1/2
• Flt3L in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003431Phase 1
• Sulindac and Plant Compounds in Preventing Colon CancerTerminatedNCT00003365Not applicable
• Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal CancerCompletedNCT00003360Phase 1
• Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal CancerCompletedNCT00003354Phase 3
• Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00003287Phase 3
• Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal CancerStatus unknownNCT00003260Phase 3
• SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to FluorouracilCompletedNCT00003254Phase 2
• Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003225Phase 1/2
• Bryostatin 1 in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003220Phase 2
• Diagnostic Procedure for Identifying Patients With Metastatic Colorectal CancerCompletedNCT00003186Not applicable
• Biological Therapy With Combination Chemotherapy in Patients With Colorectal CancerStatus unknownNCT00003063Phase 3
• Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal CancerCompletedNCT00003057Phase 3
• Interleukin-12 in Treating Patients With Cancer in the AbdomenCompletedNCT00003046Phase 1
• Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal CancerStatus unknownNCT00003001Phase 1/2
• Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal CancerCompletedNCT00002997Phase 2
• Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00002933Phase 2
• Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal CancerStatus unknownNCT00002896Phase 3
• Palliative Chemotherapy in Treating Patients With Advanced Colorectal CancerStatus unknownNCT00002893Phase 3
• Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal CancerCompletedNCT00002828Phase 1
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal CancerCompletedNCT00002801Phase 1
• Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal CancerStatus unknownNCT00002793Phase 3
• Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerCompletedNCT00002716Phase 3
• Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverStatus unknownNCT00002692Phase 3
• Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal CancerWithdrawnNCT00002664Phase 2
• High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically RemovedCompletedNCT00002650Phase 2
• Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of DiseaseCompletedNCT00002570Phase 3
• Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically RemovedCompletedNCT00002527Phase 3
• Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and CarriersCompletedNCT00001693Phase 1
• A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the LiverCompletedNCT00001576Phase 1
• Phase II Study of the Role of Anti-CEA Antibody Immunoscintigraphy & Positron Emission Tomography in the Localization of Recurrent Colorectal Carcinoma in Patients With Rising Serum CEA Levels in the Absence of Imageable Disease by Conventional ModalitiesCompletedNCT00001568Phase 2
• A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal CancerCompletedNCT00001428Phase 2

← Colorectal Neoplasms overview